UK markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.7922+0.0022 (+0.28%)
At close: 04:00PM EDT
0.7900 -0.00 (-0.28%)
After hours: 06:24PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-118,513
-118,513
-85,474
-88,441
8,410
Depreciation & amortisation
259
259
248
248
209
Stock-based compensation
13,730
13,730
17,734
20,785
14,835
Change in working capital
10,167
10,167
-12,924
5,263
-7,367
Accounts receivable
495
495
-3,260
0
0
Inventory
-438
-438
201
-2,584
0
Other working capital
-94,453
-94,453
-78,773
-60,126
-5,836
Other non-cash items
2,679
2,679
1,422
1,306
-21,456
Net cash provided by operating activities
-92,078
-92,078
-78,730
-60,087
-5,487
Cash flows from investing activities
Investments in property, plant and equipment
-2,375
-2,375
-43
-39
-349
Purchases of investments
-113,605
-113,605
-95,685
-208,795
-232,881
Sales/maturities of investments
159,441
159,441
224,435
204,013
212,955
Net cash used for investing activities
43,461
43,461
128,707
-4,751
-20,275
Cash flows from financing activities
Common stock issued
1,117
1,117
0
44,969
38,449
Other financing activities
36,474
36,474
-
-
-
Net cash used provided by (used for) financing activities
38,151
38,151
311
46,608
39,140
Net change in cash
-10,466
-10,466
50,288
-18,230
13,378
Cash at beginning of period
64,149
64,149
13,861
32,091
18,713
Cash at end of period
53,683
53,683
64,149
13,861
32,091
Free cash flow
Operating cash flow
-92,078
-92,078
-78,730
-60,087
-5,487
Capital expenditure
-2,375
-2,375
-43
-39
-349
Free cash flow
-94,453
-94,453
-78,773
-60,126
-5,836